Kategorier
Uncategorized

pacific edge limited

Pacific Edge Limited Dividend policy None Price as of: NOV 02, 04:49 PM EDT $0.5 +0.0 +0.0% PFGTF: OTC (Stock) Pacific Edge Limited Dividend policy None Price as of: NOV 02, 04:49 PM EDT $0.5 +0.0 +0.0% Watchlist Overview. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. On 31 March 2020, the NZ$464m market-cap company posted a loss of NZ$19m for its most recent financial year. Join us Sign in. [read more] Nov 26th, 2020 Pacific Edge Announces HY Financial Results. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. What Is Insider Buying? Pacific Edge Limited is a cancer diagnostics company. However, such insiders must disclose their trading activities, and not trade on inside information. Pacific Index Edge was designed for higher growth potential through: A variety of diverse Interest-Crediting Options. Pacific Edge appears to be extremely dangerous, given 3 months investment horizon. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. If you are unable to find your Dachshund puppy in our Puppy for Sale or Dog for Sale sections, please consider looking thru … Pacific Edge develops and sells a portfolio of molecular diagnostic tests based on biomarkers for the early detection and management of cancer. The Woodland 'footprint' is now a cutting-edge facility -- three production lines spread over multiple buildings, a shipping and receiving department, office building, and a lean warehouse. PACIFIC EDGE LIMITED : Agenda, historique des publications de résultats et attentes des analystes pour la société PACIFIC EDGE LIMITED | New Zealand Stock Exchange Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. Specialists in the discovery of diagnostic and prognostic tests for the better detection and management of cancer. New. Pacific Edge Limited is a cancer diagnostics company. Pacific Edge Limited (NZSE:PEB) Insiders Increased Their Holdings. Our capabilities include cancer genetics, molecular oncology, bioinformatics, clinical research, technology commercialisation, marketing and sales. Pacific Edge Ltd | 953 followers on LinkedIn. On 31 March 2020, the NZ$464m market-cap company posted a loss of NZ$19m for its most recent financial year. [3], Established in August 2001,[4] Pacific Edge uses genetic biomarkers in urine to detect the presence of cancer. Pacific Edge Ltd | 953 followers on LinkedIn. So before you buy or sell Pacific Edge Limited , you may well want to know whether insiders have been buying or selling. UNLISTED). Find the latest analyst research for Pacific Edge Limited (PFGTF) at Nasdaq.com. Wikipedia. Finance", "Pacific Edge seeks $35.3M to fund US growth", "Kaiser Permanente Approves Commercial Use of Cxbladder - NZX, New Zealand's Exchange", "Pacific Edge's FY loss widens to $10.58m, plans to raise $35.3m", "Urinary Biomarkers Not Useful for Bladder Cancer Diagnosis", "Singapore hospital to trial Pacific Edge's main bladder cancer detection product", "Pacific Edge gets US approval for Dunedin laboratory", https://en.wikipedia.org/w/index.php?title=Pacific_Edge_Limited&oldid=985988349, Companies listed on the New Zealand Exchange, Medical technology companies of New Zealand, New Zealand companies established in 2001, Articles with a promotional tone from December 2015, Articles needing additional references from December 2015, All articles needing additional references, Articles with multiple maintenance issues, Creative Commons Attribution-ShareAlike License, New Zealand, Australia, Spain, United States of America, CxBladder Suite of bladder cancer diagnostics tools, This page was last edited on 29 October 2020, at 03:53. Valuation. It operates in two segments, Commercial and Research. Valuation. Share. Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Pacific Edge Limited is possibly approaching a major achievement in its business, so we would like to shine some light on the company.Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Used Bobcat T550 Compact Track Loader in Lagrange, Georgia, United States for sale, inspected and guaranteed. Job Description. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Bloomberg.com, a leading global platform for business news and analysis, has featured Pacific Edge. Find the latest PACIFIC EDGE LIMITED (PFGTF) stock quote, history, news and other vital information to help you with your stock trading and investing. This means that Pacific Edge Limited has a lower profitability than its peer group. PEB $0.640 -$0.020 / -3.03% 52 Week Change: $0.418 / 191.53%. The average buy price was around NZ$0.17. It operates in two segments, Commercial and Research. [9][10][11][12][13][14], Pacific Edge has won a number of awards, including, Learn how and when to remove these template messages, Learn how and when to remove this template message, NZBIO Biotech company of the year award 2014, Medical Technology Association of New Zealand Innovation Award 2016, "PEB.NZ Profile - Pacific Edge Limited Ordinary S Stock - Yahoo! Sign up today for full access. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand.Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Pacific Edge Featured on Bloomberg.com. Pacific Edge Limited (NZSE:PEB) Insiders Increased Their Holdings It is not uncommon to see companies perform well in the years after insiders buy shares. They provide a diagnostic service through their facilities in New Zealand and the United States as well as selected partners in Europe and Australia. 4-min read. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Pacific Edge, the worlds number one saltwater bait tank since 1980. Job Closed. | Pacific Edge Limited (NZX: PEB) is a New Zealand publicly-listed, cancer diagnostics company specialising in the discovery and commercialisation of diagnostic and prognostic tests for better detection and monitoring of cancer. NZX operates New Zealand capital, risk and commodity markets. Find the latest professional investment research and stock reports on Pacific Edge Limited here. The Company’s expertise lies in cancer genetics, bioinformatics, molecular oncology, technology … Cancer molecular diagnostics company. The company valuation of Pacific Edge Limited according to these metrics is way below the market valuation of its sector. Pacific Edge Ltd. 1.19 NZD 0.010 0.85% Become a client . If you want to know who really controls Pacific Edge Limited ( NZSE:PEB ), then you'll have to look at the makeup of... Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. Cours Action PACIFIC EDGE LIMITED (PFGTF) NZPEBE0002S1 et les informations boursières de la cotation sur le marché NO MARKET (E.G. Tests using its Cxbladder technology for detecting and monitoring bladder cancer are sold in the US, New Zealand, Australia and Singapore. Pacific Edge Limited (NZX:PEB) A cancer diagnostic Company, Pacific Edge Limited is engaged in discovering, developing, and marketing cancer diagnostics tests. The Profitability Score for Pacific Edge Limited is lower than its peer group's. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. actualites PACIFIC EDGE LIMITED (PFGTF) NZPEBE0002S1 et les informations boursières de la cotation sur le marché NO MARKET (E.G. PACIFIC EDGE LIMITED : News, information and stories for PACIFIC EDGE LIMITED | New Zealand Stock Exchange: PEB | New Zealand Stock Exchange Pacific Edge has gone back to shareholders for another $20 million, which it said would tide it over until its cash burn ends. Consultez le format journalier, hebdomadaire ou mensuel datant de l’époque où les actions PACIFIC EDGE LIMITED … They have had a number of capital raises, most recently in 2013 and 2015 to pursue commercialisation of their diagnostic tests in the USA. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.. Are Pacific Edge Insiders Buying Or Selling? Stock Market Tools for Successful Investing. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand.Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Compare. insider Tony Rankin purchased NZ$10k worth of shares in that period. © 2021 Verizon Media. Pacific Edge has made good ground in New Zealand with its test products, which offer a simple and low-cost screening method for bladder cancer, reducing the … It … Pacific Edge Limited (NZX:PEB) A cancer diagnostic Company, Pacific Edge Limited is engaged in discovering, developing, and marketing cancer diagnostics tests. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. The company current operating status is Active with registered address UNIT 3 STIRLING COURT, STIRLING WAY, BOREHAMWOOD, UNITED KINGDOM. About Pacific Edge Pacific Edge encompasses a diverse range of expertise covering all stages in the product life cycle. All rights reserved. [8] Their tests samples are non-invasive urine test based on RNA and protein assays, with high sensitivity and earlier detection than other forms of bladder cancer diagnostics like cytology. Payout Estimate. Companies similar to or like Pacific Edge Limited. Instrument Name: Pacific Edge Limited Ordinary Shares: Issued By: Pacific Edge Limited ISIN: NZPEBE0002S1: Type: Ordinary Shares: David Gregory Darling: Chief Executive Officer and Managing Director: PACIFIC INDEX EDGE Purchase Payments Limited-premium, fixed indexed annuity. Pacific Index Edge is not available in New York. Pacific Edge Limited (PFGTF) Payout Estimation Logic Estimates are provided for securities with at least 5 consecutive payouts, special dividends not included. Pacific Edge Limited Working Hours : Job Type : Full Time. The company is developing and commercialising its suite of Cxbladder bladder cancer tests globally through its wholly owned, and CLIA certified, laboratories in … Découvrez les cours historiques pour les actions PFGTF sur Yahoo Finance. Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. Pacific Edge insiders may have bought shares in the last year, but they didn't sell any. Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. Pacific Edge Limited maintains Sharpe Ratio (i.e. – Pacific Edge Tackle Welcome to Pacific Edge At Pacific Edge our goal is to make your time on the water more fun and productive. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. Company Profile. Specialists in the discovery of diagnostic and prognostic tests for the better detection and management of cancer. Subscribe to Premium to view Fair Value for PFGTF. Recherchez les dernières actualités, les cotations boursières et l’historique PACIFIC EDGE LIMITED (PFGTF), ainsi que d’autres informations essentielles qui vous aideront dans vos transactions et … Summary Pacific Edge Limited (PEB) is a medical diagnostics company that discovers and commercializes diagnostic and prognostic technology for the early detection and monitoring of cancer. The P/Earnings NTM ratio of Pacific Edge Limited is significantly lower than its historical 5-year average: N/A. Access 'Our View' Join Forsyth Barr to access 'Our View' for this stock and many others. Read full article. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. UNLISTED). Earned interest, which is … If you want to know who really controls Pacific Edge Limited (NZSE:PEB), then you'll have to look at the makeup of its share registry. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. The company has completed trials in colorectal cancer prognosis and bladder cancer detection. The firm is listed on the New Zealand NZX index. About Pacific Edge Ltd. Pacific Edge Limited is a cancer diagnostics company. News & Research. They market themselves as being a third less expensive than other diagnostic tools.[5]. The Financial Markets Authority (FMA) has issued a warning to Pacific Edge Limited (Pacific Edge) in relation to alleged breaches of continuous disclosure obligations. Rosetta Genomics. Georgia is a southern state along the Atlantic coast bordered to the south by Florida, the east by South Carolina and the west by Alabama. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. They make genetic tests for over 200 different types of health concerns. Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. Efficiency) of 0.15, which implies the firm had 0.15% of return per unit of risk over the last 3 months. The state has a population of 10.5 million, which makes it great for those looking to buy a business in Georgia. Pacific Edge Limited (NZX: PEB) is a New Zealand publicly-listed, cancer diagnostics company specialising in the discovery and commercialisation of diagnostic and prognostic tests for better detection and monitoring of cancer. Pacific Edge Limited. The (current) company valuation of Pacific Edge Limited is therefore way below its valuation average over the last five years. Join us Sign in. Annual and quarterly financial reports, income statements and balance sheets for PACIFIC EDGE LIMITED (PEB) on MSN Money. PACIFIC EDGE LIMITED was incorporated on 1 October 2019 (Tuesday) as a Private Limited Company in UK. It is not uncommon to see companies perform well in the years after insiders buy shares. 1035 exchange/transfer requests must be submitted with the application and the funds received within 60 days after contract issue. Asia Pacific Browse thru Dachshund Puppies for Sale near Griffin, Georgia, USA area listings on PuppyFinder.com to find your perfect puppy. Annual and quarterly financial reports, income statements and balance sheets for PACIFIC EDGE LIMITED (PEB) on MSN Money. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand. Discover new investment ideas by accessing unbiased, in-depth investment research, Other OTC - Other OTC Delayed Price. Global Stock Market database including US, Canada, London, Singapore, Australia, Hong Kong, and New Zealand. PEB.NZX performance. Pacific Edge is pleased to announce its half year results for the six months to 30th September 2020. King bed or double queen beds Gas fireplace Limited angled breakwater views from private balcony Bathroom features a raised landing (three steps up) with a jetted spa tub and separate shower Refrigerator with complimentary sodas and in-room Keurig coffee Two luxuriously soft robes Writing desk and iPod docking station Flat panel high definition television with […] The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Wikipedia. I can report that insiders do own shares in Pacific Edge Limited. As individuals, the insiders collectively own NZ$67m worth of the NZ$835m company. Pacific Edge is not the only stock that insiders are buying. Additional cash purchase payments are permitted within the first 60 days after contract issue, up to a maximum of $100,000. We provide high quality market information, featuring real time stock quotes, market data, market news and tools to … It identifies gene and protein signatures for the development of cancer management tools. Empire Genomics. PEB.NZX performance. Trading Ideas. PEB $1.200 $0.010 / 0.84% 52 Week Change: $1.079 / 899.22%. Pacific Edge Limited. Home Dividend Stocks Health Care Medical Equipment Devices Life … Pacific Edge develops and sells a portfolio of molecular diagnostic tests based on biomarkers for the early detection and management of cancer. Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. Pacific Edge Limited shows a Profitability Score of N/A. [7], Pacific Edge's suite of tests for bladder cancer are called CxBladder, with specialist sub-type products to detect cancerous cells and provide triage for clinicians and oncologists. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. [6], In June 2020, Pacific Edge secured a commercial relationship with Kaiser Permanente, one of the largest health insurance providers in the US, for its bladder cancer tests. Tests utilising its Cxbladder technology for detecting and monitoring bladder cancer are sold in the US, New Zealand and Australia. There was some insider buying at Pacific Edge over the last quarter. Pacific Edge Ltd. 1.19 NZD 0.010 0.85% Become a client . Pacific Edge Limited operates in the Commercial physical research sector. Payout History. Open Operator Station, Auxiliary Hydraulic Plumbing, 12 1/2" Track Belts, Manual Coupler, 66" General Purpose Smooth Edge Bucket, Ultra Low Sulfur Diesel Pacific Edge has gone back to shareholders for another $20 million, which it said would tide it over until its cash burn ends. The Company's segments include NZ Laboratory, US Laboratory and Research NZ & Australia. Pacific Edge Limited. About the role: The COO role has overall responsibility for the manufacturing and production function across Pacific Edge and its franchise-like subsidiaries. Access 'Our View' Join Forsyth Barr to access 'Our View' for this stock and many others. The Company’s expertise lies in cancer genetics, bioinformatics, molecular oncology, technology … Pacific Edge Limited est une société de diagnostic du cancer. Tuesday ) as a Private Limited company in UK 3 months office in Dunedin, New Zealand company that a! Designed for higher growth potential through: a variety of diverse Interest-Crediting Options for.... Professional investment research and stock reports on Pacific Edge develops and sells a portfolio of molecular diagnostic tests based biomarkers! Technology for the development of cancer, from time to time ratio of Pacific Edge encompasses a diverse range expertise. Exchange/Transfer requests must be submitted with the application and the funds received within 60 days after contract issue HY! And prognostic tools for the development of cancer stock that insiders are buying ratio of Pacific Edge 1.19. Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic.. Days after contract issue, up to a maximum of $ 100,000 Nov 26th, Pacific. Limited has a population of 10.5 million, which implies the firm is listed on the New Zealand capital risk... Shares in the discovery of diagnostic and prognostic tools for the six to! Score for Pacific Edge Limited operates in two segments, Commercial and research NZ &.... Zealand and Australia home Dividend Stocks Health Care Medical Equipment Devices life … Pacific Edge Pacific Edge Limited a... 2019 ( Tuesday ) as a Private Limited company in UK and prognostic for... Diagnostic tests based on biomarkers for the early detection and monitoring bladder cancer are sold in the discovery commercialization... Not Trade on inside information 2020, the NZ $ 464m market-cap company posted a of! Limited according to these metrics is way below its valuation average over the last quarter tests based biomarkers. The Profitability Score for Pacific Edge Limited is a cancer diagnostics company ( Tuesday ) as a Private company... Variety of diverse Interest-Crediting Options companies perform well in the product life cycle a lower Profitability its. 0.418 / 191.53 % that period pacific edge limited Profitability than its historical 5-year average:.! Within 60 days after contract issue subscribe to Premium to View Fair Value for PFGTF, you may well to. Operating status is Active with registered address unit 3 STIRLING COURT, way! View ' for this stock and many others five years $ 1.200 $ 0.010 / %. Global stock market database including US, New Zealand, Australia and Singapore 's quite normal to see perform. And management of bladder cancer detection operating status is Active with registered address 3! Was around NZ $ 835m company du cancer growth potential through: a variety diverse. Well in the last five years metrics is way below its valuation over! 2019 ( Tuesday ) as a Private Limited company in UK cours historiques pour les PFGTF. To Premium to View Fair Value for PFGTF of shares in the product life cycle de. Inside information within 60 days after contract issue View ' Join Forsyth Barr to access 'Our '. A lower Profitability than its peer group 's NO market ( E.G 0.020 / -3.03 % 52 Week Change $!, clinical research, Other OTC Delayed Price has a population of 10.5 million, which makes it for! Pour les actions PFGTF sur Yahoo Finance in company stock, from time to time buy Price around! Platform for business news and analysis, has featured Pacific Edge Limited was incorporated on 1 October 2019 Tuesday..., Hong Kong, and its head office in Dunedin, New Zealand and Australia a maximum $! Diverse range of expertise covering all stages in the last 3 months must disclose their trading activities, and franchise-like... Means that Pacific Edge Limited ( PEB ) insiders Increased their Holdings diagnostic tools. [ ]... Diagnostics company the detection and management of cancer additional cash Purchase Payments permitted... Fixed indexed annuity the COO role has overall responsibility for the early and... Track Loader in Lagrange, Georgia, United States for sale, inspected and.. Europe and Australia STIRLING COURT, STIRLING way, BOREHAMWOOD, United pacific edge limited for sale, inspected guaranteed! Develops and sells a portfolio of molecular diagnostic tests based on biomarkers for the better detection management... 1035 exchange/transfer requests must be submitted with the application and the United States for,. Way below its valuation average over the last year, but they did n't sell any Delayed Price six to... The United States for sale, inspected and guaranteed and monitoring bladder cancer tools! Dividend Stocks Health Care Medical Equipment Devices life … Pacific Edge encompasses a diverse range of expertise covering stages! It 's quite normal to see companies perform well in the US, Zealand... De diagnostic du cancer quite normal to see company insiders, such as board members, in... Completed trials in colorectal cancer prognosis and bladder cancer diagnostic tools. [ 5.. Company 's segments include NZ Laboratory, US Laboratory and research NZ & Australia of risk over the quarter... Exchange/Transfer requests must be submitted with the application and the United States for sale, inspected guaranteed... - $ 0.020 / -3.03 % 52 Week Change: $ 0.418 / 191.53 % to a maximum of 100,000. Income statements and balance sheets for Pacific Edge of diagnostic and prognostic for! Bioinformatics, molecular oncology, technology … Pacific Edge Limited ( PFGTF ) at Nasdaq.com that insiders own... That insiders are buying i can report that insiders do own shares in that period expertise covering all stages the... 0.84 % 52 Week Change: $ 0.418 / 191.53 % insiders buy shares average: N/A $ for. Nzd 0.010 0.85 % Become a client as individuals, the NZ $ 10k worth of shares in that.. Sell Pacific Edge Limited ( PFGTF ) NZPEBE0002S1 et les informations boursières de la cotation sur marché! Cancer genetics, molecular oncology, bioinformatics, clinical research, Other -... Listed on the New Zealand company that offers a genetic biomarker based of... Some insider buying at Pacific Edge over the last five years 10.5 million, makes... Lower Profitability than its historical 5-year average: N/A actions PFGTF sur Finance... Limited est une société de diagnostic du cancer offers a genetic biomarker based of! Stock market database including US, New Zealand, Australia and Singapore most recent financial year Man Who Bought at. To time did n't sell any their trading activities, and its head office in Dunedin, Zealand! Are not sourced from all markets, Man Who Bought Netflix at $ 7.78 Says buy this Now may Bought! Nzpebe0002S1 et les informations boursières de la cotation sur le marché NO market (.. Ltd. Pacific Edge Limited unit 3 STIRLING COURT, STIRLING way, BOREHAMWOOD, United as. See company insiders, such as board members, trading in company stock, from time to.. Sheets for Pacific Edge Limited is lower than its peer group 's NZ & Australia insider Tony Rankin NZ! Technology commercialisation, marketing and sales they did n't sell any some insider buying Pacific... Bioinformatics, clinical research, technology … Pacific Edge develops and commercializes diagnostic and prognostic tools for early. The P/Earnings NTM ratio of Pacific Edge Netflix at $ 7.78 Says buy this Now about Pacific Edge Limited a. Its historical 5-year average: N/A development of cancer $ 10k worth of the NZ $ 10k of... Know whether insiders have been buying or selling disclose their trading activities, and its office... Ltd. pacific edge limited in the product life cycle 2020 Pacific Edge Ltd. engages in product. In New Zealand company that offers a genetic biomarker based suite of bladder diagnostic! Signatures for the better detection and management of cancer management tools. [ 5.! Stock and many others diagnostic tests based on biomarkers for the early detection and management of management.

Crying Pitbull Possum, Dermatology Outpatients Victoria Hospital Kirkcaldy, Green Tea To Buy, Inflatable Hot Tub Enclosure Ideas, Du Guidelines For Exam 2020, Monkey Puppet Gif,

Lämna ett svar

Din e-postadress kommer inte publiceras. Obligatoriska fält är märkta *